2020-05-14T19:42:27-05:00 2019-06-30 910189318 MOSS ADAMS LLP 999 THIRD AVENUE SUITE 2800 SEATTLE WA 98104 990 2018-07-01 911019655 BLOODWORKS BLOO 2062926500 921 TERRY AVENUE SEATTLE WA 981041256 ROBERT GLEASON CHIEF FINANCIAL OFFICER 2066896680 2020-05-05 1 COLLEEN RAMIRES P01251320 2063026500 2020-05-05 67.161.92.235 2020-05-05 18:45:25 PD P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 C07EA3D2EFE7589B691C7C6F5A7C1991A329BAB3 2018 2021-01-29 14:40:06Z CURT BAILEY 921 TERRY AVENUE SEATTLE WA 981041256 225025926 0 X WWW.BLOODWORKSNW.ORG X 1944 WA SAVING LIVES THROUGH RESEARCH, INNOVATION, EDUCATION & EXCELLENCE IN BLOOD, MEDICAL & LAB SERVICES. 19 18 1107 1840 0 0 1034605 1671845 194400628 204928770 2311050 2547120 186025 575201 197932308 209722936 1740182 3140152 0 0 80587370 79004044 33328 35209 1669803 121374187 130997752 203735067 213177157 -5802759 -3454221 147232810 139133799 54054758 48805558 93178052 90328241 SAVING LIVES THROUGH RESEARCH, INNOVATION, EDUCATION AND EXCELLENCE IN BLOOD, MEDICAL AND LABORATORY SERVICES IN PARTNERSHIP WITH OUR COMMUNITY. 0 0 174799292 196292664 RECRUIT DONORS, COLLECT, TEST, PROCESS AND FRACTIONATE WHOLE BLOOD AND COMPONENTS INTO TRANSFUSION READY PRODUCTS (WHOLE BLOOD, RED BLOOD CELLS, PLATELETS, PLASMA AND CRYOPRECIPITATE) FOR USE IN NEARLY 90 HOSPITALS, PRIMARILY LOCATED IN THE PACIFIC NORTHWEST. 14360069 3140152 8636106 WE ARE A RESEARCH INSTITUTE WITH OVER 75 YEARS OF RESEARCH AND DISCOVERIES. BLOODWORKS SCIENTISTS HAVE TRANSFORMED PATIENT CARE WITH BREAKTHROUGHS IN TRANSFUSION MEDICINE, BLOOD BIOLOGY, BLOOD STORAGE, CANCER THERAPIES, ORGAN TRANSPLANTATION, AND TREATMENT OF CLOTTING DISORDERS. TODAY, OUR STAFF OF 50 SCIENTISTS ACROSS 9 LABORATORIES CONTINUES TO SEARCH FOR NEW KNOWLEDGE AND NEW TECHNOLOGIES TO IMPROVE PATIENT CARE. BLOODWORKS' SCIENTISTS CAN BE FOUND IN MEDICAL SCHOOLS AND AT SCIENTIFIC FORUMS SHARING THE LATEST BLOOD SCIENCE WITH DOCTORS FROM AROUND THE REGION - AND AROUND THE WORLD. 189159361 1 1 0 1 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 1 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 224 0 1 1107 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 X 19 18 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 0 WA OR X ROBERT GLEASON 2066896680 921 TERRY AVENUE SEATTLE WA 981041256 HOLLI HARRIS BOARD CHAIR (THRU 3/19) 1.00 X X 0 0 0 CRAIG SMITH MD BOARD CHAIR & INTERIM CEO 1.00 X X 0 0 0 W CONRAD LILES MD PHD BOARD VICE CHAIR 1.00 X X 0 0 0 JOHN FITZHARRIS MD BOARD TRUSTEE 1.00 X 0 0 0 DAVID CHICHESTER BOARD TRUSTEE 1.00 X 0 0 0 ANNE DAFFERN BOARD TRUSTEE 1.00 X 0 0 0 MOLLY FIRTH BOARD TRUSTEE 1.00 X 0 0 0 PAT FORCE BOARD TRUSTEE (THRU 6/19) 1.00 X 0 0 0 CARLA FOWLER MD PHD BOARD TRUSTEE (THRU 6/19) 1.00 X 0 0 0 JIM GARRISON BOARD TRUSTEE 1.00 X 0 0 0 HUNTER GRAHAM GOODMAN JD BOARD TRUSTEE (THRU 12/18) 1.00 X 0 0 0 WILLIAM HAMMOND MD BOARD TRUSTEE (THRU 6/19) 1.00 X 0 0 0 CRAIG HENDRICKSON BOARD TRUSTEE 1.00 X 0 0 0 MEREDITH MATHEWS MD BOARD TRUSTEE (THRU 6/19) 1.00 X 0 0 0 JIM PALMERI BOARD TRUSTEE 1.00 X 0 0 0 SEAN W SIGMON BOARD TRUSTEE 1.00 X 0 0 0 CRAIG M TREWET BOARD TRUSTEE 1.00 X 0 0 0 PHYLLIS T TURNER-BRIM ESQ BOARD TRUSTEE (THRU 9/18) 1.00 X 0 0 0 BOB WALLACE BOARD TRUSTEE (THRU 6/19) 1.00 X 0 0 0 GLENN WISEGARVER BOARD TRUSTEE (THRU 6/19) 1.00 X 0 0 0 MARK HULAK BOARD TRUSTEE 1.00 X 0 0 0 JAMES AUBUCHON MD PRESIDENT & CEO (THRU 5/19) 40.00 X X 902247 0 40320 CURT BAILEY PRESIDENT & CEO 40.00 X X 0 0 0 ROBERT GLEASON TREASURER & CFO 40.00 X 264261 0 53660 MAXINE SELLERS SECRETARY 40.00 X 72384 0 17767 LINDA BARNES CHIEF OPERATING OFFICER (THRU 8/18) 40.00 X 263790 0 39020 KARYN DENTON VP CLINICAL SERVICES (THRU 6/19) 40.00 X 194985 0 36446 CHRISTINE DONATELLI CHIEF QUALITY OFFICER 40.00 X 218195 0 42087 YANYUN WU MD CHIEF MEDICAL OFFICER 40.00 X 372725 0 15023 JAMES ZIMRING MD PHD CHIEF SCIENTIFIC OFFICER (THRU 6/19) 40.00 X 531159 0 32690 BARBARA KONKLE MD CHIEF SCIENTIFIC OFFICER 40.00 X 322087 0 31824 JOSE LOPEZ MD RESEARCHER 40.00 X 315311 0 40736 KRISTEN ALCORN MEDICAL DIRECTOR 40.00 X 284616 0 28603 REBECCA KRUSE-JARRES MD MEDICAL DIRECTOR 40.00 X 255997 0 21380 PAUL WARNER PHD ASHI MEDICAL DIRECTOR 40.00 X 259736 0 35111 JIN-FEI DONG MD RESEARCHER 40.00 X 235936 0 42253 THERESA NESTER MD MEDICAL DIR. (FORMER KEY EMPLOYEE) 40.00 X 234072 0 33815 4727501 0 510735 112 1 1 0 BN BUILDERS INC 2601 4TH AVENUE SUITE 350 SEATTLE WA 98121 CONSTRUCTION SERVICES 1225903 NUWEST GROUP HOLDINGS LLC PO BOX 40285 BELLEVUE WA 98015 TEMPORARY HELP 857556 DEGREE 37 LLC 14594 NW TREE TOP LANE SEABECK WA 98380 CONSULTANTS 769613 NINE75 LLC 1001 FOURTH AVENUE SUITE 4500 SEATTLE WA 98154 CONSULTANTS 743980 MEDIA PLUS 160 ROY STREET SEATTLE WA 98109 MARKETING 489838 39 280393 1391452 1671845 SERVICE FEES 541900 108594162 108594162 BLOOD DERIVATIVES 339110 85785375 85785375 RESEARCH REVENUE 541700 8636106 8636106 DELIVERY FEES 480000 539775 539775 JOINT VENTURE INVESTMENT 621500 129377 129377 1243975 1243975 204928770 1562548 1562548 1417630 820052 597578 597578 597578 15215685 54753 14246413 39453 969272 15300 984572 984572 174695 280393 197072 -22377 -22377 209722936 204928770 0 3122321 2949442 2949442 189710 189710 1000 1000 3986172 1414265 2571907 58944568 49417173 8546267 981128 4039991 3310419 693713 35859 6631740 6281086 253619 97035 5401573 4187272 1138629 75672 663259 343194 320065 120000 120000 35209 35209 263840 263840 5514224 4347634 1152526 14064 2003943 1189592 745599 68752 3725081 1889316 1814714 21051 4092419 3320225 709673 62521 6404716 5079794 1215235 109687 379459 276453 82599 20407 244002 101571 135353 7078 986548 4550 972293 9705 6743030 5443036 1192371 107623 928790 749411 164529 14850 DRUGS & SUPPLIES 95475204 95475204 TRANSPORTATION 2761092 2496869 255061 9162 PROVISION FOR BAD DEBT 692145 692145 213177157 189159361 22347993 1669803 2107637 6660590 3051231 2088866 25825218 26718272 2770299 2408015 2600695 4723035 140715691 95103697 50045130 45611994 59348853 50096720 40641 318092 1443106 508215 147232810 139133799 33464921 29203923 20589837 19601635 54054758 48805558 X 88393487 85596060 1468716 1402331 3315849 3329850 93178052 90328241 147232810 139133799 X -3454221 456336 148074 X 0 1 X 1 1 1 X 11548534 1510536 1421459 1034605 1671845 17186979 161263038 175586838 174503908 194400628 204928770 910683182 200510 181353 184651 174748 174695 915957 173012082 177278727 176110018 195609981 206775310 928786118 6879157 502912 276559 222500 189870 8070998 0 6879157 502912 276559 222500 189870 8070998 920715120 2693945 2636355 2937686 2862117 2980178 14110281 2693945 2636355 2937686 2862117 2980178 14110281 175706027 179915082 179047704 198472098 209755488 942896399 0.97650 0.97380 0.01500 0.01590 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 0 1 12651 0 0 12651 0 PART II-B, LINE 1: BLOODWORKS EXECUTIVES AND OTHER STAFF MET WITH WASHINGTON STATE LEGISLATORS WHILE HOSTING A BLOOD DRIVE AT WASHINGTON STATE CAPITAL CAMPUS. A BLOODWORKS' EMPLOYEE SPENT ONE DAY MEETING WITH MULTIPLE LEGISLATIVE STAFF MEMBERS IN WASHINGTON D.C. 3660095 14000 204975 536432 3342638 3800128 -238400 100678 2311 3660095 3625990 8500 165638 3800128 3581374 3545 41071 3625990 446312 3104500 33444 2882 3581374 0.00000 0.99600 0.00400 0 0 1300000 1618261 2918261 50811293 24971334 25839959 18489613 16197461 2292152 58082543 48533619 9548924 10413981 5401283 5012698 45611994 X 210922495 575652 575652 210346843 263840 -887747 -623907 209722936 213772306 858989 858989 212913317 263840 263840 213177157 PART V, LINE 4: INTENDED USE OF ENDOWMENT FUND EARNINGS IS FOR MEDICAL RESEARCH AS WELL AS AN ANNUAL LECTURE SERIES. PART X, LINE 2: THE ORGANIZATION IS A NOT-FOR-PROFIT CORPORATION AND HAS BEEN RECOGNIZED AS TAX-EXEMPT PURSUANT TO SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE ORGANIZATION IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE EXCEPT TO THE EXTENT OF UNRELATED BUSINESS TAXABLE INCOME AS DEFINED UNDER IRC SECTIONS 511 THROUGH 515. ANY UNRELATED BUSINESS INCOME GENERATED IS NOT SIGNIFICANT; THEREFORE, NO PROVISION FOR INCOME TAXES HAS BEEN RECORDED. THE ORGANIZATION HAS ADOPTED ACCOUNTING FOR UNCERTAIN TAX POSITIONS. THE ACCOUNTING STANDARDS PRESCRIBES A RECOGNITION THRESHOLD AND MEASUREMENT PROCESS FOR UNCERTAIN TAX POSITIONS. AS OF JUNE 30, 2019 AND 2018, THE ORGANIZATION HAD NO UNCERTAIN TAX POSITIONS REQUIRING ACCRUAL. PART XI, LINE 4B - OTHER ADJUSTMENTS: RENTAL EXPENSES NETTED WITH RENTAL REVENUE -820,052. FUNDRAISING FEES NETTED WITH FUNDRAISING REVENUE -197,072. JOINT VENTURE INVESTMENT BOOK/TAX ADJUSTMENT -148,074. JOINT VENTURE INVESTMENT GAIN RECLASSIFIED TO EXPENSE 277,451. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES NETTED WITH RENTAL REVENUE 820,052. FUNDRAISING FEES NETTED WITH FUNDRAISING REVENUE 197,072. JOINT VENTURE INVESTMENT GAIN RECLASSIFIED TO EXPENSE -277,451. UNREALIZED LOSS ON INTEREST RATE SWAP 119,316. MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES CONFERENCES 6117 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES ISTH MEETING 3382 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES RESEARCHING & ASSISTING AFRICA WITH IT'S BLOOD COLLECTION TECHNIQUES. AFSBT MEETING. 2503 EUROPE 0 0 PROGRAM SERVICES ISBT, ISTH, AND BEST MEETINGS 9049 NORTH AMERICA 0 0 PROGRAM SERVICES ISBT MEETING 1126 0 0 0 0 0 0 22177 0 22177 0 0 0 0 0 0 X X X X X X X 1 TOLO EVENTS LLC 3131 WESTERN AVENUE SUITE 326 SEATTLE WA 98121 CONSULTING FOR THE BLOODWORKS BALL 0 455088 35209 419879 455088 35209 419879 WA OR BLOODWORKS BALL 455088 280393 174695 74066 12210 110796 455088 280393 174695 74066 12210 110796 197072 -22377 1 BAYLOR COLLEGE ONE BAYLOR PLAZA HOUSTON TX 770303411 741613878 PUBLIC UNIVERSITY 58950 VWF ACTIVITY: MOLECULAR BIOLOGY, ETHNIC DIVERSITY & DISEASE ASSOCIATIONS EMORY UNIVERSITY 1599 CLIFTON RD NE 4TH FLOOR ATLANTA GA 303224250 580566256 PUBLIC UNIVERSITY 469164 IMMUNOBIOLOGY OF TRANSFUSION OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK ROAD PORTLAND OR 972393098 931176109 PUBLIC UNIVERSITY 8699 COMPARISON OF IDEAL VS ACTUAL WEIGHT BASE FACTOR DOSING PROVIDENCE HEALTH SERVICES - WASHINGTON DBA PROVIDENCE SACRED HEART MEDICAL 101 WEST 8TH AVENUE SPOKANE WA 99204 510216586 501(C)(3) 7936 COMPARISON OF IDEAL VS ACTUAL WEIGHT BASE FACTOR DOSING SEATTLE CHILDREN'S RESEARCH INSTITUTE 4800 SAND POINT WAY NE SEATTLE WA 98105 910564748 501(C)(3) 33856 BLEEDING DISORDERS COLLABORATIVE COORDINATING CENTER ACTIVITIES TERUMO BCT INC 10811 W COLLINS AVE LAKEWOOD CO 80215 841155788 410634 ARMY PREPS (US ARMY MEDICAL RESEARCH ACQUISITION ACT) UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 104 AIRPORT DRIVE CAMPUS BOX 1220 CHAPEL HILL NC 275991220 566001393 PUBLIC UNIVERSITY 141422 VWF ACTIVITY: MOLECULAR BIOLOGY, ETHNIC DIVERSITY & DISEASE ASSOCIATIONS UNIVERISTY OF WASHINGTON 4333 BROOKLYN AVE SEATTLE WA 981959472 916001537 PUBLIC UNIVERSITY 29124 1. CARDIOVASCULAR DISEASES RESEARCH2. MOLECULAR AND TRANSLATIONAL STUDIES IN HEMATOLOGIC DISORDERS3. CLINICAL EFFECTIVENESS OF STANDARD VS MIRASOL-TREATED APHERESIS PLATELETS IN PATIENTS WITH HPOPROLIFERATIVE THROMBOCYTOPENIA UNIVERSITY OF VIRGINIA PO BOX 400195 CHARLOTTESVILLE VA 229044195 546001796 PUBLIC UNIVERSITY 561836 1. IMMUNOBIOLOGY OF TRANSFUSION2. SERIOUS HAZARDS OF TRANSFUSION & CELLULAR THERAPIES: MECHANISMS & INTERVENTION YALE UNIVERSITY 25 SCIENCE PARK - 3RD FLOOR 100 MUNSON ST NEW HAVEN CT 065208327 060646973 501(C)(3) 1227820 IMMUNOBIOLOGY OF TRANSFUSION 9 1 RESEARCH PARTICIPANTS FOR BLOOD STUDIES 494 189710 PART I, LINE 2: MONITORING/REVIEW/PROCEDURES: PRIOR TO ISSUING A SUBAWARD, BLOODWORKS REVIEWS THE ENTITY ON WWW.SAM.GOV FOR DEBARMENT OR SUSPENSION FROM RECEIVING FEDERAL FUNDS AND CONFIRMS THE CCR STANDING OF THE ENTITY. GRANT AND CONTRACTS SPECIALIST REVIEWS THIS INFORMATION ANNUALLY. IN ADDITION, BLOODWORKS RECEIVES AND REVIEWS THE ANNUAL OMB SINGLE AUDIT FOR OUR SUBRECIPIENTS AND ADDRESSES ANY FINDINGS FROM THE AUDIT. THE SUBAWARD IDENTIFIES THE MAXIMUM AMOUNT OF AWARD AND BLOODWORKS STAFF VERIFIES THAT THE PAYMENTS DO NOT EXCEED THIS AMOUNT. SUBRECIPIENTS ARE SELECTED BASED ON THE NEEDS OF THE AWARD AND WHICH ORGANIZATION IS ABLE TO BEST PARTNER WITH THE PRINCIPAL INVESTIGATOR. X X 1 1 X X X X 0 1 0 0 0 0 0 1 0 JAMES AUBUCHON MD PRESIDENT & CEO (THRU 5/19) 667873 0 0 0 234374 0 21252 0 19068 0 942567 0 0 0 ROBERT GLEASON TREASURER & CFO 259261 0 5000 0 0 0 27500 0 26160 0 317921 0 0 0 LINDA BARNES CHIEF OPERATING OFFICER (THRU 8/18) 263790 0 0 0 0 0 18620 0 20400 0 302810 0 0 0 KARYN DENTON VP CLINICAL SERVICES (THRU 6/19) 194985 0 0 0 0 0 14290 0 22156 0 231431 0 0 0 CHRISTINE DONATELLI CHIEF QUALITY OFFICER 218195 0 0 0 0 0 11724 0 30363 0 260282 0 0 0 YANYUN WU MD CHIEF MEDICAL OFFICER 372725 0 0 0 0 0 14387 0 636 0 387748 0 0 0 JAMES ZIMRING MD PHD CHIEF SCIENTIFIC OFFICER (THRU 6/19) 344497 0 186662 0 0 0 19250 0 13440 0 563849 0 0 0 BARBARA KONKLE MD CHIEF SCIENTIFIC OFFICER 322087 0 0 0 0 0 19250 0 12574 0 353911 0 0 0 JOSE LOPEZ MD RESEARCHER 315311 0 0 0 0 0 27500 0 13236 0 356047 0 0 0 KRISTEN ALCORN MEDICAL DIRECTOR 284616 0 0 0 0 0 14359 0 14244 0 313219 0 0 0 REBECCA KRUSE-JARRES MD MEDICAL DIRECTOR 255997 0 0 0 0 0 12836 0 8544 0 277377 0 0 0 PAUL WARNER PHD ASHI MEDICAL DIRECTOR 259736 0 0 0 0 0 26087 0 9024 0 294847 0 0 0 JIN-FEI DONG MD RESEARCHER 235936 0 0 0 0 0 17397 0 24856 0 278189 0 0 0 THERESA NESTER MD MEDICAL DIR. (FORMER KEY EMPLOYEE) 234072 0 0 0 0 0 24090 0 9725 0 267887 0 0 0 PART I, LINE 1A FIRST CLASS TRAVEL IS PROVIDED TO THE PRESIDENT UNDER VERY SPECIFIC AND APPROVED CIRCUMSTANCES. SOCIAL CLUB DUES WERE PROVIDED FOR THE PRESIDENT. SOCIAL CLUBS ARE USED FOR BUSINESS RELATED MEETINGS. PART I, LINE 4B SCHEDULE J, PART I, LINE 4B: BLOODWORKS HAS A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN ESTABLISHED TO PROVIDE ADDITIONAL RETIREMENT COMPENSATION TO DR. JAMES AUBUCHON, PRESIDENT AND CEO. AS OF SEPTEMBER 2015 DR. AUBUCHON WAS FULLY VESTED IN THE PLAN. FOR THE CURRENT YEAR, DR. AUBUCHON RECEIVED A DISTRIBUTION OF $234,374 FROM THE PLAN. PART I, LINE 7 THE BOARD DETERMINES AND APPROVES THE BONUSES FOR THE CEO, DR. AUBUCHON. IF APPLICABLE OTHER EMPLOYEE BONUSES ARE CONTRACTUALLY DRIVEN BY THE TERMS OF THEIR EMPLOYMENT AGREEMENTS. HUMAN RESOURCES REVIEWS AND MAINTAINS EMPLOYMENT AGREEMENTS. DR. AUBUCHON'S BONUS IS AT THE DISCRETION OF THE BOARD. A WA ECONOMIC DEVELOPMENT FINANCE AUTHORITY 911493002 2014-09-15 24140000 PURCHASE AND RENOVATION OF RENTON, WA FACILITY 0 0 0 A 4569530 24140000 209442 23930558 2009 1 0 1 1 A 0 1 1 1 0 0 0 1 A 0 1 0 0 1 0 0 0 1 A 1 PART II, LINE 14 THE PURPOSE OF THIS BOND WAS TO PROVIDE FUNDS FOR A REFUNDING OF BONDS ISSUED AUGUST 14, 2008. FORM 990, PART VI, SECTION B, LINE 11B INTERNALLY, DATA FOR THE FORM 990 IS PREPARED BY THE ACCOUNTING DEPARTMENT AND REVIEWED BY THE CONTROLLER AND THE CHIEF FINANCIAL OFFICER. THE FORM 990 IS THEN PREPARED BY OUR CPA FIRM. EXTERNAL REVIEW CONSISTS OF THE FORM 990 BEING POSTED TO THE BOARD OF TRUSTEES WEBSITE, AND THE BOARD MEMBERS ARE EMAILED A LINK TO THIS PASSWORD PROTECTED SITE SO THAT THE FORM 990 CAN BE REVIEWED. FORM 990, PART VI, SECTION B, LINE 12C BLOODWORKS HAS ALL HUMAN RESOURCE POLICIES (INCLUDING CONFLICT OF INTEREST) ONLINE AND ACCESSIBLE. ANY CHANGES ARE HIGHLIGHTED AND SENT TO ALL EMPLOYEES. UPON HIRE AND UPON MAJOR POLICY CHANGES, EMPLOYEE SIGNS ACKNOWLEDGEMENT FORM TO EVIDENCE THAT SHE/HE IS RESPONSIBLE TO READ AND BECOME ACQUAINTED WITH THE POLICIES. ANNUALLY BOARD MEMBERS MUST SIGN A FORM AND DISCLOSE CONFLICTS OF INTEREST. THESE ARE REVIEWED BY THE BOARD CHAIR AND PRESIDENT. IF A CONFLICT OF INTEREST EXISTS, AN INTERESTED PERSON MAY MAKE A PRESENTATION, BUT MUST LEAVE THE MEETING DURING ANY DISCUSSION OF THE MATTER. THE CHAIRPERSON MAY, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON TO INVESTIGATE ALTERNATIVES. THE BOARD OR COMMITTEE SHALL EXERCISE DUE DILIGENCE TO DETERMINE WHETHER THE ORGANIZATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT THAT DOES NOT CREATE A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE COMMITTEE OF THE BOARD REVIEWS AND APPROVES THE PRESIDENT'S COMPENSATION BASED ON RESEARCH OF OTHER COMPARABLE ORGANIZATIONS AND INDUSTRY STANDARDS PERFORMED BY A COMPENSATION CONSULTING FIRM. IN 2018 AN OUTSIDE CONSULTING FIRM PROVIDED TRENDS IN BOTH PERFORMANCE INCREASES AND BONUSES FOR CEOS. THE BOARD USED THIS INFORMATION IN THE PRESIDENT'S COMPENSATION REVIEW. KEY EMPLOYEE AND OFFICER SALARIES ARE REVIEWED AGAINST MARKET DATA WITH CONSIDERATION OF INTERNAL EQUITY. MARKET DATA INCLUDES ANNUAL SURVEY FROM INDUSTRY ASSOCIATION AND COMPARISON TO ADDITIONAL REGIONAL AND NATIONAL MARKET DATA APPROXIMATELY EVERY TWO TO THREE YEARS. IN ADDITION, MEDICAL STAFF SALARIES ARE REVIEWED AGAINST UNIVERSITY RANGES FOR PHYSICIANS OF LIKE SPECIALTIES. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. BLOODWORKS HAS ALL HUMAN RESOURCE POLICIES (INCLUDING CONFLICT OF INTEREST) ONLINE AND ACCESSIBLE. FORM 990, PART XI, LINE 9: JOINT VENTURE INVESTMENT BOOK/TAX ADJUSTMENT 148,074. CHARITABLE REMAINDER TRUST (1) CHARITABLE TRUST WA N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0